goserelin
Selected indexed studies
- Goserelin ('Zoladex')--offering patients more choice in early breast cancer. (Eur J Oncol Nurs, 2004) [PMID:15590321]
- Clinical pharmacokinetics of goserelin. (Clin Pharmacokinet, 2000) [PMID:10926349]
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. (Drugs, 1996) [PMID:8808170]
_Worker-drafted node — pending editorial review._
Connections
goserelin is a side effect of
Sources
- Goserelin ('Zoladex')--offering patients more choice in early breast cancer. (2004) pubmed
- Clinical pharmacokinetics of goserelin. (2000) pubmed
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. (1996) pubmed
- Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women. (2005) pubmed
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer. (1995) pubmed
- Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women. (2001) pubmed
- Erythema nodosum caused by goserelin acetate sustained-release: Case report and literature review. (2023) pubmed
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions. (1991) pubmed
- Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. (2006) pubmed
- Goserelin acetate implant: a depot luteinizing hormone-releasing hormone analog for advanced prostate cancer. (1991) pubmed